The number of drug-resistant tuberculosis (TB) cases is rising globally. But a newly discovered natural antibiotic — produced by bacteria from the lung infection in a cystic fibrosis patient — could help fight these infections.
Lab testing reported in the Journal of the American Chemical Society shows that the compound is active against multi-drug resistant strains.
Starting with the famous first discovery of penicillin from mold, scientists have continued to search for natural sources of antibiotics. And as pathogens develop resistance to once-reliable medicines, the search has taken on a new urgency. By 2040, more than a third of all TB cases in Russia, for example, could show resistance to first-line drugs currently used to fight the disease, a recent report published in Lancet estimates. Among potential new drug sources are species of the bacterial genus Burkholderia that thrive in a wide range of habitats, from soil to the human lung. One way these microbes have adapted to these diverse environments is by making potent antibiotics to take out their competition. In light of the growing threat of drug-resistant bacteria, particularly among TB strains, Gregory L. Challis, Eshwar Mahenthiralingam and colleagues wanted to see if Burkholderia might produce a promising anti-TB compound.
The researchers discovered that one species, Burkholderia gladioli, which was isolated from the sputum of a child with cystic fibrosis, produces an antibiotic called gladiolin. The compound belongs to the same structural class as etnangien, another antibiotic that has been investigated for its ability to jam bacterial cell machinery. But etnangien is highly unstable. The researchers found that gladiolin is much more stable than etnangien, and could therefore potentially be a better drug candidate. Lab testing also showed that gladiolin blocked the growth of four drug-resistant TB strains.
Learn more: Bacteria from cystic fibrosis patient could help thwart antibiotic-resistant TB
[osd_subscribe categories=’tuberculosis’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “TUBERCULOSIS”‘]
The Latest on: Antibiotic-resistant TB
[google_news title=”” keyword=”antibiotic-resistant TB” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Experts developing immune-enhancing therapies to treat TB: Studyon April 28, 2024 at 9:32 am
Experts are developing revolutionary immune-enhancing medicines known as host-directed therapies, which employ the body’s immune system to target TB, to tackle even drug-resistant strains of the ...
- Enhancing Immunity to Combat Tuberculosison April 27, 2024 at 8:59 am
Researchers explore host-directed therapies, harnessing the body's immune system to combat tuberculosis, including drug-resistant strains.
- Experts develop immune-enhancing therapies to target tuberculosison April 26, 2024 at 3:10 pm
Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the ...
- Africa: TB Clinical Trials: An UnPrecedented €34 Million Price Tag in Drug Developmenton April 26, 2024 at 11:10 am
Press Release - At the 5th WHO Pharmaceutical Pricing and Reimbursement Policies conference today, Doctors Without Borders (MSF) presented the costs of its landmark TB-PRACTECAL clinical trial that ...
- Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy, claims studyon April 25, 2024 at 8:31 am
Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking ...
- In first such test, bedaquiline cures 4 kids of drug-resistant TBon April 21, 2024 at 7:51 pm
Bedaquiline treatment at JJ Hospital shows promise in treating pre-XDR-TB in children under five. The drug's success in younger patients may lead to b ...
- Whole genome sequencing could be key to detecting drug-resistant TB, shows studyon April 17, 2024 at 5:33 am
India faces challenges because of low investment in public health programs, high endemicity in difficult-to-reach locations, and persisting diagnostic gaps.
- Significant challenge posed by drug-resistant TB strains to efficacy of treatment, control measures: Studyon April 17, 2024 at 1:44 am
The findings highlighted resistance not only to rifampicin, a drug used to manage and treat diverse mycobacterial infections, and isoniazid, an antibiotic indicated in the first-line treatment of ...
- Absence of full drug-susceptibility data for TB patients can result in amplifying resistance: studyon April 16, 2024 at 7:48 pm
Study by HaystackAnalytics & Dr. D.Y. Patil Medical College reveals high prevalence of pre-XDR-TB in MDR-TB cases in India.
- Indian Study Shows Whole-Genome Sequencing Key To Detect Drug-Resistant TB Earlyon April 16, 2024 at 2:20 am
With India aiming to eliminate tuberculosis (TB) by 2025, five years ahead of the global target, whole-genome sequencing ( ...
via Google News and Bing News